SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
X	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* Presidio Partners 2007, L.P. (Last) (First) (Middle) ONE LETTERMAN DRIVE BUILDING C, SUITE CM500 (Street) SAN FRANCISCO CA 94129 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol Neos Therapeutics, Inc. [ NEOS ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 07/27/2015
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/28/2015		C		406,250	A	(1)	406,250	D
Common Stock	07/28/2015		C		677,622	A	(1)	1,083,872	D
Common Stock	07/28/2015		C		162,500	A	(2)	1,246,372	D
Common Stock	07/28/2015		C		10,416	A	(1)	1,256,788	I	by Presidio Partners 2007 (Parallel), L.P
Common Stock	07/28/2015		C		17,374	A	(1)	1,274,162	I	by Presidio Partners 2007 (Parallel), L.P
Common Stock	07/28/2015		C		4,166	A	(2)	1,278,328	I	by Presidio Partners 2007 (Parallel), L.P

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Series B Preferred Stock	(1)	07/28/2015		C			975,000	(1)	(1)	Common Stock	406,250	(1)	0	D
Series C Preferred Stock	(1)	07/28/2015		C			1,626,294	(1)	(1)	Common Stock	677,622	(1)	0	D
Preferred Stock Warrant (Right to Buy)	(1)	07/27/2015		X			390,000	(3)	01/30/2018	Series C Preferred Stock	390,000	(3)	0	D
Series C Preferred Stock	(1)	07/28/2015		C			390,000	(1)	(1)	Common Stock	162,500	(1)	0	D
Series B Preferred Stock	(1)	07/28/2015		C			25,000	(1)	(1)	Common Stock	10,416	(1)	0	I	By Presidio Partners 2007 (Parallel), L.P.
Series C Preferred Stock	(1)	07/28/2015		C			41,700	(1)	(1)	Common Stock	17,374	(1)	0	I	By Presidio Partners 2007 (Parallel), L.P.
Preferred Stock Warrant (Right to Buy)	(3)	07/27/2015		X			10,000	(3)	01/30/2018	Series C Preferred Stock	10,000	(3)	0	I	By Presidio Partners 2007 (Parallel), L.P.
Series C Preferred Stock	(1)	07/28/2015		C			10,000	(1)	(1)	Common Stock	4,166	(1)	0	I	By Presidio Partners 2007 (Parallel), L.P.

1. Name and Address of Reporting Person* Presidio Partners 2007, L.P. (Last) (First) (Middle) ONE LETTERMAN DRIVE BUILDING C, SUITE CM500 (Street) SAN FRANCISCO CA 94129 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Presidio Partners 2007 (Parallel), L.P. (Last) (First) (Middle) ONE LETTERMAN DRIVE BUILDING C, SUITE CM500 (Street) SAN FRANCISCO CA 94129 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Presidio Partners 2007 GP, L.P. (Last) (First) (Middle) ONE LETTERMAN DRIVE BUILDING C, SUITE CM500 (Street) SAN FRANCISCO CA 94129 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Collier David J (Last) (First) (Middle) ONE LETTERMAN DRIVE BUILDING C, SUITE CM500 (Street) SAN FRANCISCO CA 94129 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Watson James F (Last) (First) (Middle) ONE LETTERMAN DRIVE BUILDING C, SUITE CM500 (Street) SAN FRANCISCO CA 94129 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Presidio Partners 2007 GP, LLC (Last) (First) (Middle) ONE LETTERMAN DRIVE BUILDING C, SUITE CM500 (Street) SAN FRANCISCO CA 94129 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Sohail Faysal A. (Last) (First) (Middle) ONE LETTERMAN DRIVE BUILDING C, SUITE CM500 (Street) SAN FRANCISCO CA 94129 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

Explanation of Responses:

1. Each share of the Issuer's Series B preferred stock and Series C preferred stock was automatically converted on a 2.4-for-1 basis into common stock immediately prior to the closing of the Issuer's initial public offering. The shares of Series B preferred stock and Series C preferred stock had no expiration date.

2. Based upon and including the number of shares of common stock listed in column 4 issued upon the automatic conversion of the underlying shares of Series C preferred stock in accordance with Footnote (1) above, such shares of Series C preferred stock issued in accordance with the warrant exercise set forth in Footnote (3) below.

3. The preferred stock warrant was exercised in full on July 27, 2015 for the number of underlying shares of Series C preferred stock. The shares of Series C preferred stock have no expiration date.

Remarks:

	PRESIDIO PARTNERS 2007, L.P. By: Presidio Partners 2007 GP, L.P., its General Partner By: Presidio Partners 2007 GP LLC, its General Partner /s/ David J. Collier, Manager	07/28/2015
	Presidio Partners 2007 (Parallel), L.P. By: /s/ David J. Collier, Manager	07/28/2015
	Presidio Partners 2007 GP, L.P. /s/ David J. Collier, Manager	07/28/2015
	/s/ David J. Collier	07/28/2015
	/s/ James F. Watson	07/28/2015
	Presidio Partners 2007 GP, LLC /s/ David J. Collier, Manager	07/28/2015
	/s/ Faysal A. Sohail	07/28/2015
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.